Mangoceuticals (MGRX) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to -$0.69.
- Mangoceuticals' EPS (Weighted Average and Diluted) rose 3947.37% to -$0.69 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.11, marking a year-over-year increase of 4737.73%. This contributed to the annual value of -$4.4 for FY2024, which is 4871.93% up from last year.
- According to the latest figures from Q3 2025, Mangoceuticals' EPS (Weighted Average and Diluted) is -$0.69, which was up 3947.37% from -$0.57 recorded in Q2 2025.
- In the past 5 years, Mangoceuticals' EPS (Weighted Average and Diluted) registered a high of -$0.14 during Q2 2023, and its lowest value of -$1.9 during Q4 2023.
- For the 3-year period, Mangoceuticals' EPS (Weighted Average and Diluted) averaged around -$1.05, with its median value being -$1.14 (2024).
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 87857.14% in 2024, then surged by 5839.42% in 2025.
- Quarter analysis of 3 years shows Mangoceuticals' EPS (Weighted Average and Diluted) stood at -$1.9 in 2023, then skyrocketed by 48.18% to -$0.98 in 2024, then rose by 29.92% to -$0.69 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.69 for Q3 2025, versus -$0.57 for Q2 2025 and -$1.29 for Q1 2025.